LASA SUPERGENERICS
Back to Income Statement
|
LASA SUPERGENERICS Last 5 Year Revenue History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Sales | ₹104 Cr | ₹130 Cr | ₹137 Cr | ₹202 Cr | ₹167 Cr |
What is the latest Revenue of LASA SUPERGENERICS ?
| Year | Revenue |
|---|---|
| Mar2024 | ₹104 Cr |
| Mar2023 | ₹130 Cr |
| Mar2022 | ₹137 Cr |
| Mar2021 | ₹202 Cr |
| Mar2020 | ₹167 Cr |
How is Revenue of LASA SUPERGENERICS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2024 | ₹104 Cr | -19.47 | |
| Mar2023 | ₹130 Cr | -5.51 | |
| Mar2022 | ₹137 Cr | -32.24 | |
| Mar2021 | ₹202 Cr | 21.00 | |
| Mar2020 | ₹167 Cr | - | |
Compare Revenue of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹57.8 Cr | 23.1% | 15.3% | -58.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,319.0 Cr | 2.4% | -2.5% | -7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,383.0 Cr | 3.9% | 2.6% | 3.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,241.0 Cr | 2.5% | 4.1% | 12.3% | Stock Analytics | |
| CIPLA | ₹123,617.0 Cr | 1.3% | 0.6% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,825.0 Cr | -1.2% | -1.5% | -9.1% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | 23.1% |
15.3% |
-58.9% |
| SENSEX | 0.5% |
-0.2% |
8.4% |
You may also like the below Video Courses